Slideshow
Canadian researchers looked at the safety of short-term use in patients with hypertension, heart failure, or chronic kidney disease.
Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks
Emerging Agents in the Treatment of Rheumatic Diseases
Understanding Ultra-Processed Food Intake and Risk of Lupus
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
IV Secukinumab Rapidly Improved Clinical Responses in Psoriatic Arthritis
Long-term Opioids for Fibromyalgia Linked to Depression, Sleep Issues